| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000033004 |
| Receipt No. | R000036752 |
| Official scientific title of the study | Investigation on EBV infection status and immunosuppressive treatment in Japanese IBD patients |
| Date of disclosure of the study information | 2018/07/01 |
| Last modified on | 2018/06/15 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Investigation on EBV infection status and immunosuppressive treatment in Japanese IBD patients | |
| Title of the study (Brief title) | EBISU study | |
| Region |
|
|
| Condition | ||
| Condition | inflammatory bowel disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In this study, we investigate the EBV antibody titer of patients with IBD including children and clarify the prevalence of EBV infection by age. Then, it compares with the use situation of IBD therapeutic agent, especially thiopurine preparation and biological preparation, and clarifies the actual situation in Japan. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Rate of EBV infection by age in patient with IBD |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient with IBD of all age. | |||
| Key exclusion criteria | Patient who can not obtain consent of participation in this study. | |||
| Target sample size | 510 | |||
| Research contact person | |
| Name of lead principal investigator | Tadakazu Hisamatsu |
| Organization | Kyorin University School of Medicine |
| Division name | The Third Department of Internal Medicine |
| Address | 6-20-2 Shinkawa Mitaka Tokyo |
| TEL | 0422-47-5511 |
| thisamatsu@ks.kyorin-u.ac.jp | |
| Public contact | |
| Name of contact person | Miki Miura |
| Organization | Kyorin University School of Medicine |
| Division name | The Third Department of Internal Medicine |
| Address | 6-20-2 Shinkawa Mitaka Tokyo |
| TEL | 0422-47-5511 |
| Homepage URL | |
| jasmine.miu.m@gmail.com | |
| Sponsor | |
| Institute | Kyorin University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | As a cross sectional observational study, we will clarify the status of EBV infection by age.
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036752 |